Peek into the Process

A series of articles in the Journal of the American Medical Association this week examines the US Food and Drug Administration's approval process.

One paper from a Yale University School of Medicine-based group looks at the evidence supporting FDA's decisions to approve nearly 190 drugs between 2005 and 2012. Joseph Ross, an assistant professor of medicine at Yale, and his colleagues report that the clinical trial evidence justifying each approval varies in quality.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.